Thomasville National Bank boosted its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 2.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 82,961 shares of the technology company’s stock after buying an additional 2,183 shares during the quarter. Veeva Systems makes up about 1.3% of Thomasville National Bank’s holdings, making the stock its 27th biggest position. Thomasville National Bank owned approximately 0.05% of Veeva Systems worth $17,443,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA raised its holdings in shares of Veeva Systems by 64.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,545,451 shares of the technology company’s stock valued at $744,084,000 after purchasing an additional 1,392,256 shares in the last quarter. State Street Corp raised its holdings in Veeva Systems by 1.5% in the 3rd quarter. State Street Corp now owns 3,293,141 shares of the technology company’s stock worth $691,132,000 after acquiring an additional 47,872 shares during the period. FMR LLC raised its holdings in Veeva Systems by 25.7% in the 3rd quarter. FMR LLC now owns 2,981,244 shares of the technology company’s stock worth $625,674,000 after acquiring an additional 610,021 shares during the period. Geode Capital Management LLC raised its holdings in Veeva Systems by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,765,236 shares of the technology company’s stock worth $579,630,000 after acquiring an additional 149,807 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in Veeva Systems by 73.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,558,592 shares of the technology company’s stock worth $536,972,000 after acquiring an additional 1,081,501 shares during the period. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Insider Activity at Veeva Systems
In other news, SVP Jonathan Faddis sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total value of $390,128.20. Following the completion of the transaction, the senior vice president now owns 8,061 shares in the company, valued at $1,856,448.30. This represents a 17.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas D. Schwenger sold 1,126 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the transaction, the insider now owns 27,013 shares of the company’s stock, valued at $6,483,390.13. This trade represents a 4.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 10.50% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Report on Veeva Systems
Veeva Systems Stock Down 1.9 %
NYSE VEEV traded down $4.14 during trading on Monday, reaching $213.61. 348,433 shares of the stock traded hands, compared to its average volume of 925,940. The firm has a market cap of $34.68 billion, a price-to-earnings ratio of 52.74, a price-to-earnings-growth ratio of 2.03 and a beta of 0.84. The stock’s 50-day moving average price is $222.97 and its 200 day moving average price is $208.78. Veeva Systems Inc. has a fifty-two week low of $170.25 and a fifty-two week high of $258.93.
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- What Do S&P 500 Stocks Tell Investors About the Market?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is Short Interest? How to Use It
- Delta Can Fly to New Highs in 2025; Here’s Why
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.